-
PROMETRIKA is pleased to present the fifth issue of our biannual newsletter. We want to keep you informed of our growth and the progress of our internal initiatives and technological and methodological innovations, which directly translate to more and better services for your clinical research programs. We hope you will enjoy reading about PROMETRIKA’s recent accomplishments and activities.
-
A message from PROMETRIKA’s President and CEO
The Global COVID-19 pandemic is having a profound impact on communities and individuals worldwide. Our daily lives have changed drastically and the sequelae of this pandemic are likely to be long-lasting. PROMETRIKA continues to monitor the evolving picture of COVID-19 spread worldwide as well as the pharmaceutical and biotechnology companies’ and clinical research community’s extraordinary and tireless efforts to combat this disease by developing vaccines and novel treatments. In these unprecedented times, we remain focused and committed to our core values of excellence, flexibility, and above all caring for the well-being of our sponsors, patients, employees and their families.
-
We are partnering in the Global COVID-19 Trials.
-
On February 26th, 2020, double alumna of BU Department of Mathematics - Miganush Stepanians, President and CEO of PROMETRIKA, LLC spoke at BU’s Masters in Statistical Practice [MSSP] Statistics at Work Series. This program invites speakers from the industry to present on data-centric challenges that accompany a career in this sector, and the manner in which statistical training can help meet those challenges.
-
PROMETRIKA is pleased to present the fourth issue of our biannual newsletter. As the year 2019 comes to a close, we look back on all we have celebrated and accomplished and look forward to all the new opportunities 2020 has to offer.
Follow Us